Annals of Surgical Oncology Cite Track
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
10.1245/s10434-007-9794-9
Annals of Surgical Oncology 15:1092-1098 (2008)
© 2008 Society of Surgical Oncology
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Google Scholar
Right arrow Articles by Khanfir, K.
Right arrow Articles by Zouhair, A.
PubMed
Right arrow Articles by Khanfir, K.
Right arrow Articles by Zouhair, A.

Original Article

Patterns of Failure and Outcome in Patients with Carcinoma of the Anal Margin

Kaouthar Khanfir, MD1, Mahmut Ozsahin, MD, PhD2, Sabine Bieri, MD1, Christiano Cavuto, MD2, René O. Mirimanoff, MD2 and Abderrahim Zouhair, MD2

1 Department of Radiation Oncology, Hôpital de Sion, Grand-Champsec 81, CH-1051, Sion, Switzerland
2 Department of Radiation Oncology, Centre Hospitalier Universitaire Vaudois (CHUV) and University of Lausanne, Lausanne, Switzerland

Correspondence: Address correspondence and reprint requests to: Kaouthar Khanfir, MD; E-mail: kaouthar.khanfir{at}rsv-gnw.ch

Background: To evaluate the outcome of patients with carcinoma of anal margin in terms of recurrence, survival, and radiation toxicity.

Methods: A series of 45 consecutive patients, with anal margin carcinoma treated between 1983 and 2006 with curative intent at two institutions, was retrospectively analyzed. A surgical excision (close or positive surgical margin in 22 out of 29 patients) was realized before radiotherapy (RT). RT consisted of definitive external beam RT (EBRT) in 36 patients, brachytherapy (BT) alone in two patients, and both BT and EBRT in seven patients. The median total radiation dose was 59.4 Gy (range, 30–74 Gy).

Results: The 5-year locoregional control (LRC) rate was 78% [95% confidence interval (CI), 64–93%]. The 5-year disease-specific survival (DSS) and overall survival (OS) rates were respectively 86% (95% CI, 72–99%) and 55% (95% CI, 44–66%). The overall anal conservation rate was 80% for the whole series. There was no significant association between local recurrence and patient age, histological grade, tumor size, T stage, overall treatment time, RT dose, or chemotherapy. Long-term side effects were observed in 15 patients (33%). Only three patients developed grade 3–4 late toxicity (CTCAE/NCI v3.0). Significant relationship was found between dose, and complication rate (48% for dose ≥59.4 Gy versus 8% for dose < 59.4 Gy; P = 0.03).

Conclusions: We conclude that definitive RT and/or BT yield a good local control and disease-specific survival comparable with published data. This study suggests that radiation dose over 59.4 Gy seems to increase treatment-related morbidity.

Key Words: Anal margin cancer • Radiotherapy • Brachytherapy • Sphincter preservation






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2008 by the Society of Surgical Oncology.